Genentech

OCREVUS

Manufacturer:

Genentech

Ocrevus HCPCS:

J2350

HCPCS Code Descriptor:

Injection, ocrelizumab, 1 mg

Category:

J Code

Ocrevus NDCs:

50242-0150-01

Primary Type:

Neurology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Ocrevus:

OCREVUS is a Neurology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J2350 is aligned to the drug OCREVUS.

ACCESS PRICING AND MORE BY REGISTERING

J2350 Added Date:

January 1, 2018

J2350 Effective Date:

January 1, 2018

J2350 Termination Date:

HCPCS Active

Ocrevus billing and coding information can be found through Genentech at the link below:
Ocrevus patient assistance information can be found through Genentech at the URL: https://www.gene.com/patients/patient-foundation
OCREVUS prescribing information can be found at the link below:
Information regarding OCREVUS’s side effects can be found at MedlinePlus